The largest community of pharma leaders

Pharmatech Promotes Mustafa Abdallah to Executive Leadership Role

HAYWARD, Calif.–()–Pharmatech Associates today announced the promotion of Mustafa Abdallah to the position of vice president, regulatory compliance, from his previous role as director. Mr. Abdallah works with a broad array of life science organizations, drug and device sponsors, and contract manufacturing solution providers.

“Pharmatech has assembled one of the most diverse professional teams in the industry, and I am particularly pleased when our associates produce results leading to promotion to our Executive Leadership Team,” said Warren Baker, chief executive officer, Pharmatech Associates. “Mustafa’s outstanding personal character, technical excellence, and influential leadership qualities embody the very definition of a trusted advisor, dedicated to solving the global regulatory problems our clients face.”

Mr. Abdallah brings over 20 years of experience in computer systems validation (CSV), design and deployment of quality management systems (QMS), IT operations and financial security systems within regulated life sciences environments. He holds a bachelor of science in analytical chemistry from California State University, Fresno, and a MBA from California State University, East Bay.

About Pharmatech Associates

Pharmatech Associates is a global consultancy for the life science industry, meeting the complex needs of clients with highly experienced scientists and engineering subject matter experts. Pharmatech’s team specializes in Product and Process Development, Facilities and Capital Projects, Regulatory Compliance, and Regulatory Affairs. Pharmatech advises clients that range in size from startups to large multi-national corporations on projects in Asia, Europe and North America from its headquarters in the San Francisco Bay Area. https://pharmatechassociates.com/

Source

Recent Articles

AVROBIO to Present at Two Upcoming Investor Conferences

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AVRO--AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene...

Global Neurofibromatosis Treatment Drugs Market to Surpass US$ 21,223.7 Million by 2027, Says Coherent Market Insights (CMI)

SEATTLE--(BUSINESS WIRE)-- #NeurofibromatosisTreatment--The Asia Pacific is expected to witness significant growth...

FDA Approves Nucala as the First and Only Biologic Treatment for Hypereosinophilic Syndrome (HES)

LONDON--(BUSINESS WIRE)--GlaxoSmithKline plc (GSK) (LSE/NYSE: GSK) today announced the US Food...

Novocure Honors Mesothelioma Day with Activities to Raise Awareness of Mesothelioma and Support the Community

ST. HELIER, Jersey--(BUSINESS WIRE)--Novocure announced today initiatives to bring attention to...

Veracyte Receives ADLT Status for Envisia Genomic Classifier From Centers for Medicare and Medicaid Services

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte Receives ADLT Status for Envisia Genomic...
2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.